GlaxoSmithKline Partners With Texas A&M And State Officials On $91 Million Vaccine Manufacturing Facility
03/26/2013
"GSK is privileged to deepen our commitment to U.S. public health, as part of this unprecedented public-private collaboration to protect against pandemics and bio-threats," Senior Vice President Antoon Loomans. "In Texas A&M we have found a partner with a rich tradition of service, and with pioneering technologies that will benefit the entire pharmaceutical industry in making vaccines available and accessible to all in need.
"Over the past decade, we have invested in innovative programs to prioritize research in our state at both our universities and in the private sector. This combined with Texas' workforce and business climate have made us a leader in high-tech innovation, research, development and commercialization," Gov. Rick Perry said. "Not only will this center keep Americans safer from epidemic, it will bring in more than $41 billion to the state over the next 25 years and contribute to the creation of more than 6,800 jobs in Texas."
This announcement builds on a series of significant investments the state has made over the last decade to elevate Texas to the forefront of biotech research and development, beginning in 2005, with the Texas Institute for Genomic Medicine at Texas A&M University. Later, the National Center for Therapeutics Manufacturing was established to create a skilled bio-pharmaceutical workforce proficient in therapeutics manufacturing, he added.
"We are honored to welcome GSK to Texas A&M as a key partner in the Center for Innovation," Chancellor John Sharp said. "GSK's dedication to public service is well-aligned with the Texas A&M tradition of serving the nation and defining its future through research and scholarship. Equally important is the cultural and philosophical match between GSK and the A&M System, as reflected by GSK's desire to collaborate with academia and the U.S. government, and their ongoing commitment to helping address global health scourges such as pandemic influenza and malaria."
Project Announcements
Retech Systems Expands Tonawanda, New York, Operations
09/28/2023
Viega Establishes Shalersville, Ohio, Production Operations
09/27/2023
Japan-Based Dassai Establishes Hyde Park, New York, Operations
09/26/2023
Martin Brower Plans Oshawa, Ontario, Canada, Distribution Hub
09/26/2023
Latitude Plans Clarendon County, South Carolina, Operations
09/25/2023
DePre Plans Powell, Tennessee, Production Operations
09/25/2023
Most Read
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
2022 Top States for Doing Business Provide an Environment for Business Growth
Q3 2022
-
Why the Southeast Is Winning EV Projects, With More on the Way
Q3 2023
-
EV Impacts to Watch in 2023 and 2024
2023 Auto/Aero Site Guide
-
Power-Intensive Site Selection
Q3 2023
-
EV and Semiconductor Projects Stand Out in States Receiving Area Development’s 18th Annual Shovel Awards
Q2 2023
-
2023 Top States Workforce Development Programs
Q3 2023